Molecular Oncology

Article	Citations
Issue Information	174
	100
PoDCall: a robust tool for automated droplet classification in DNA‐methylation droplet digital PCR	98
	64
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”	57
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with	46
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”	41
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma	39
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer	38
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy	38
Microglia limit brain tumor development by restricting tumor cell proliferation and inducing T‐cell immunity	38
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection	36
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system	35
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer	35
Issue Information	34
Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2 + mononuc	34
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity	34
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy	34
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer	33
Unraveling LINE ‐1 retrotransposition in head and neck squamous cell carcinoma	33
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer	30
Exosomes secreted by ST3GAL5high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment	30
An arms‐race against resistance: leukemic stem cells and lineage plasticity	29
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐ CD 73/anti‐	28
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities	28

Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1	28
Ovarian cancer relies on the PDGFRβ –fibronectin axis for tumorsphere formation and metastatic spread	26
The multispecies microbial cluster of Fusobacterium , Parvimonas , Bacteroides	26
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo	26
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling	25
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for	25
Gene signature predicting recurrence in oral squamous cell carcinoma is characterized by increased oxidative phosphorylation	25
Precision Cancer Medicine 2.0—Oncology in the postgenomic era	25
Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis	24
Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma	23
Hijacking the BAF complex: the mechanistic interplay of ARID1A and EWS::FLI1 in Ewing sarcoma	23
DNA methylation and expression of MAPRE3 affect overall survival of	23
New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treat	22
Cancer cachexia: biomarkers and the influence of age	22
Academia and society should join forces to make anti‐cancer treatments more affordable	22
Correction to: Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C	22
RETRACTION : Long Noncoding RNA ZNF667‐AS1 Reduces Tumor Invasion and Metastasis in Cervical Cancer by Counteracting Microrna‐93‐3p‐Dependent PEG3 Downregulation	22
Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer	22
Proteome‐based molecular subtyping and therapeutic target prediction in gastric cancer	21
Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration	21
ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion	21
Germline variants in CDKN2A wild‐type melanoma prone families	21
Integration of single‐cell and bulk RNA ‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer	20
Issue Information	20
Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer	20
E2A selectively regulates TGF‐β–induced apoptosis in KRAS ‐mutant non‐small cell lung cancer	20
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology	20
A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma	20
Issue Information	20
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic–mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer	20
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models	20
Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma	20
	20
Replenishing co‐downregulated miR‐100‐5p and miR‐125b‐5p in malignant germ cell tumors causes growth inhibition through cell cycle disruption	19
Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing	19
	19
DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1	18
Tetraploidy‐linked sensitization to CENP‐E inhibition in human cells	18
Retraction statement: Consistency analysis of microRNA ‐arm expression reveals microRNA ‐369‐5p/3p	18
Correction to “The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma”	18
Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblasto	18
Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples	18
The LIN28B –let‐7– PBK pathway is essential for group 3 medulloblastoma tumor growth and survival	17
Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK‐inhibitor‐induced tolerant persister cells in ALK<	17
European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions	17
Cancer as an infective disease: the role of EVs in tumorigenesis	17
Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers	17
Targeting protein folding in N‐Myc‐driven medulloblastoma	17
A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications	17
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity	16

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic	16
Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment	16
Correction to “The prostate metastasis suppressor gene NDRG 1 differentially regulates cell motility and invasion”	16
Molecular cancer prevention: Intercepting disease	16
MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness	16
Intein‐based modular chimeric antigen receptor platform for specific CD19 / CD20 co‐targeting	16
Issue Information	16
Functional loss of ERBB receptor feedback inhibitor 1 ( MIG6 ) promotes glioblastoma tumorigenesis	15
Rodent models of tumours of the central nervous system	15
RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma	15
Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorourac	15
Post‐prostatic‐massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate‐cancer‐typical micro RNA s and acti	15
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism	15
Long noncoding RNAs with peptide‐encoding potential identified in esophageal squamous cell carcinoma: KDM4A‐AS1‐encoded peptide weakens cancer cell viability and migratory capacity	14
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients	14
Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer	14
Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models	14
Assay‐agnostic spatial profiling detects tumor microenvironment signatures: new diagnostic insights for triple‐negative breast cancer	14
Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models	14
Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation	14
Abstracts	14
Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7 ‐mutated	14
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential	14
SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner	14
Interpreting the effects of DNA polymerase variants at the structural level	14
KRAS inhibitors: going noncovalent	14
Potential therapeutic targeting of BK Ca channels in glioblastoma treatment	14
Assembly of glioblastoma tumoroids and cerebral organoids: a 3Din vitro model for tumor cell invasion	13
Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers	13
Issue Information	13
ATF4 ‐mediated stress response as a therapeutic vulnerability in chordoma	13
Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel	13
European Code Against Cancer, 5th edition – tobacco and nicotine containing products, second‐hand smoke, alcohol and cancer	13
Issue Information	13
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma	13
A rapid, multiplex digital PCR assay to detect gene variants and fusions in non‐small cell lung cancer	13
Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of	13
	13
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma	13
Retraction Statement: Circ‐TCF4 .85 silencing inhibits cancer progression through microRNA ‐486‐5p	12
PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis	12
Elucidating prognostic significance of purine metabolism in colorectal cancer through integrating data from transcriptomic, immunohistochemical, and single‐cell RNA	12
Plasma extrachromosomal circular DNA as a biomarker in EGFR ‐targeted therapy of non‐small cell lu	12
Lipid metabolism in B cell biology	12
Liver X receptors induce antiproliferative effects in basal‐like breast cancer	12
Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1	12
LDAcoop : Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro	12
CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cance	12
The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma	12
Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—t	12
PP2A ‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells	12
In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma	12
Crosstalk between gut microbiota and tumor: tumors could cause gut dysbiosis and metabolic imbalance	12
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs	12
Simultaneous detection of eight cancer types using a multiplex droplet digital PCR assay	12
EXPRESSION OF CONCERN: DIMP53 ‐1: A Novel Small‐Molecule Dual Inhibitor of p53– MDM2 /X Interactio	12
Postbiotics of Lacticaseibacillus paracasei CECT 9610 and Lactiplantibacillus plantarum	11
Metabolism in the tumor cell and beyond	11
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway	11
Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic ce	11
Targeting senescence as an anticancer therapy	11
Microglia and macrophages in glioblastoma: landscapes and treatment directions	11
Copy number variations contribute to malignant tumor development in children with serious birth defects	11
COMP – PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells	11
GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL	11
Enhanced reversal of ABCG2‐mediated drug resistance by replacing a phenyl ring in baicalein with a meta ‐carborane	11
SMG1 , a nonsense‐mediated mRNA decay ( NMD ) regulator, as a candi	11
Immune escape of colorectal tumours via local LRH‐1/Cyp11b1‐mediated synthesis of immunosuppressive glucocorticoids	11
Expression of Concern: T‐ LAK cell‐originated protein kinase ( TOPK ): an emerging prognostic biom	11
Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer	11
CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR‐15b‐5p and miR‐7‐1‐3p processing in nasopharyngeal carcinoma	11
SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radi	11
Immune evasion: An imperative and consequence of MYC deregulation	11
Thioredoxin‐interacting protein ( TXNIP ) is a substrate of the NEDD4 ‐like	11
Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional valida	11
The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells	11
From bedside to portable and wearable: development of a conformable ultrasound patch for deep breast tissue imaging	11
Issue Information	11
cAMP ‐phosphodiesterase 4D7 ( PDE4D7 ) forms a	11
Protein palmitoylation in cancer: molecular functions and therapeutic potential	11

Loss of Lkb1 cooperates with Braf V600E	11
Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth	11
The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma	11
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients	11
TREX1 , a predator for treating MSI ‐H tumors?	10
Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole‐exome sequencing	10
Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma	10
ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high ( M	10
Issue Information	10
Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia	10
Engineered extracellular vesicles enriched with the miR ‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer	10
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with	10
Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma	10
Transcriptomic pan‐cancer analysis using rank‐based Bayesian inference	10
Comprehensive profiling of lncRNAs and mRNAs enriched in small extracellular vesicles for early no	10
Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location	10
Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer:	10
Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework	10
	10
The roles and applications of extracellular vesicles in cancer	10
Identifying the personalized driver gene sets maximally contributing to abnormality of transcriptome phenotype in glioblastoma multiforme individuals	10
Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ ALL pediatric patients with high	10
Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade	10
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term fol	10
Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer trea	10
Integrated analysis of racial disparities in genomic architecture identifies a trans‐ancestry prognostic subtype in bladder cancer	10
The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer	10
Interferon regulatory factor 4 modulates epigenetic silencing and cancer‐critical pathways in melanoma cells	10
Current status of precision oncology in adult glioblastoma	10
Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy	10
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model	10
Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study	10
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E	10
LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells	9
TRAIL ‐ PEG ‐Apt‐ PLGA nanosystem as an aptamer‐targeted drug deliv	9
Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog	9
PPM1D activity promotes the replication stress caused by cyclin E1 overexpression	9
Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2 ‐positive cancers	9
Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF	9
Inhibition of acyl‐ CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction	9
Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients	9
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker	9
Proximity proteomics reveals role of Abelson interactor 1 in the regulation of TAK1 / RIPK1 signal	9
PP2A methylesterase PME ‐1 suppresses anoikis and is associated with therapy relapse of	9
Predictors of response and rational combinations for the novel MCL ‐1 inhibitor MIK665 in acute my	9
Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities	9
Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity	9
The critical role of DNA damage‐inducible transcript 4 ( DDIT4 ) in stemness character of leukemia	9
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives	9
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells	9
Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance	9
In vitro and in silico modelling of ROS1 ‐positive non‐small cell lung canc	9
Viral mimicry evasion: a new role for oncogenic KRAS mutations	9
CDK 11 inhibition induces cytoplasmic p21 WAF 1	9
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis	9
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications	9
	9
Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen ther	9
Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library	9
Bovine meat and milk factor protein expression in tumor‐free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival	9
CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7 ‐	9
Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study	9
Deciphering metabolic crosstalk in context: lessons from inflammatory diseases	9
Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients	9
Targeting p38α in cancer: challenges, opportunities, and emerging strategies	9
Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in	9
Flow‐based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product	9
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration	8
Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma	8
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α	8
RNA m6Amethylation in cancer	8
A novel pipeline for prioritizing cancer type‐specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas	8
Screening for lung cancer: A systematic review of overdiagnosis and its implications	8
Detection of colorectal‐cancer‐associated bacterial taxa in fecal samples using next‐generation sequencing and 19 newly established q PCR assays	8
Cadherin‐11 increases tumor cell proliferation and metastatic potential via Wnt pathway activation	8
Optimising the European Code Against Cancer, 5th edition, to increase awareness of avoidable cancer risks in all socioeconomic groups	8
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer	8
Chimeric diphtheria toxin– CCL8 cytotoxic peptide for breast cancer management	8
Recurrence/prognosis estimation using a molecularly positive surgical margin‐based model calls for alternative curative strategies in pIIIA/N2 NSCLC	8
European Code Against Cancer, 5th edition – organised cancer screening programmes	8
RETRACTION : Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma	8
Tumour immunogenicity goes with the (mitochondrial electron) flow	8
	8
RETRACTION: NNK From Tobacco Smoking Enhances Pancreatic Cancer Cell Stemness and Chemoresistance by Creating a β2AR‐Akt Feedback Loop That Activates Autophagy	8
Malformin C preferentially kills glioblastoma stem‐like cells via concerted induction of proteotoxic stress and autophagic flux blockade	8
Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/ mTOR and	8
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and	8
Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian can	8
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?	8
Next‐generation proteomics improves lung cancer risk prediction	8
MYC and therapy resistance in cancer: risks and opportunities	8
Issue Information	8
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization	8
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER + breast cancer	8
	8